Lexaria BioscienceLEXX 
$3.22-1.23%24h
-1.23%24h
Global rank27489
Market cap$21.30M
Change 7d-
YTD Performance153.54%
SP500 benchmarkOutperform
P/E-3.19
P/S94.15
Revenue$226.21K
Earnings-$6.71M
Dividend yield-
Main Sector
Healthcare
Lexaria Bioscience (LEXX) Cash on Hand
LEXX Cash on Hand in 2022: $1.48M
According to Lexaria Bioscience latest financial reports the cash on hand of LEXX is $1.48M, an decrease of -76.01% to 2022. At the end of 2022 company had $6.16M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
LEXX Cash on Hand History from 2018 to 2023
-
Value:-
LEXX Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.48M | -76.01% |
| 2022 | $6.16M | -47.58% |
| 2021 | $11.75M | 794.97% |
| 2020 | $1.31M | -2.69% |
| 2019 | $1.35M | -22.33% |
| 2018 | $1.74M | - |
View the Top Cash on Hand Companies 
